Robert A. Douglas joined the Globus Medical Board of Directors in December of 2019 and is a member of the Board's Audit Committee. He has over thirty years of experience in medical device technology, with particular expertise in digital health, and qualifies as an audit committee financial expert.
From 2012 to 2023, Mr. Douglas served as President and Chief Operating Officer in the Office of the Chief Executive Officer for ResMed Inc. (NYSE: RMD, ASX: RMD), a medical device and software applications company specializing in cloud-connected devices whose solutions diagnose, treat and manage respiratory disorders and improve care in out-of-hospital settings.
Mr. Douglas currently serves on the Board of Directors and Audit Committee of PolyNovo Limited (ASX: PNV), a medical technology company based in Melbourne, Australia. From 2024 to 2026, he served on the Board of Directors of XCMR. Previously, he served as Vice Chairman on the Board of Directors of the San Diego Regional Economic Development Corporation and as Vice Chairman on the Board of Directors of EvoNexus, a non-profit technology incubator.
Mr. Douglas has an M.B.A. from Macquarie University, a Bachelor of Engineering, Electrical with 1st Class Honors, and a Bachelor of Science, Computer Sciences from the University of New South Wales, Sydney.